Please login to the form below

Not currently logged in
Email:
Password:

Innate Pharma

This page shows the latest Innate Pharma news and features for those working in and with pharma, biotech and healthcare.

Bad news for Innate Pharma as BMS-backed drug stumbles

Bad news for Innate Pharma as BMS-backed drug stumbles

Bad news for Innate Pharma as BMS-backed drug stumbles. Lirilumab combination fails to show additional benefit in SCCHN patients. ... French biotech Innate Pharma says it can’t see a development path forward for its lead cancer drug lirilumab after

Latest news

  • Sanofi and Novartis snap up immuno-oncology candidates Sanofi and Novartis snap up immuno-oncology candidates

    Now, the French pharma firm has added a 400m collaboration with Innate Pharma to develop bi-specific (double-headed) antibodies that will target both tumour antigens and NKp46, an activating receptor

  • Former Sanofi SVP Gilles Brisson to chair Mauna Kea

    Most recently, Brisson has held the position of chair at Innate Pharma since 2007 and Ethypharm since 2009.

  • HCV hope on the horizon

    US. Others in phase II trials are the T-lymphocyte stimulants GI 5005 (Tarmogen; GlobeImmune), a recombinant yeast product, and IPH 1101 (Phosphostim; Innate Pharma), a small molecule compound that is ... Romark Laboratories has a small molecule signal

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    The second deal closed by Sanofi was with Innate Pharma to create new bispecific antibodies, which aim to kill tumour cells through the activation of NKp46. ... 502.3. Innate Pharma/ Sanofi. Collaboration . Collaboration to develop 2 bispecific NK cell

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    Gene therapy platform - CV diseases. 2, 300. Innate Pharma / AstraZeneca. ... 225. Intec Pharma/ Undisclosed Company. R&D collaboration plus option. Accordian Pill (gastro retentive delivery system).

  • Pharma deals in April 2015 Pharma deals in April 2015

    Pharma deals in April 2015. The love affair with oncology continues, finds Medius Deal Watch. ... Continuing to build the oncology portfolio and looking to score a win with a combination therapy, AZ in-licensed Innate Pharma's IPH2201 for both

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    For an indepth analysis of these deals, read'Pharma deals during February 2014'. ... 39. Novo Nordisk / Innate Pharma. Licence with equity partial payment.

  • Pharma deals during February 2014 Pharma deals during February 2014

    II trials; this antibody was generated within the existing collaboration between Innate Pharma and Novo Nordisk. ... Innate Pharma will prioritise development of anti-NKG2A in immuno-oncology and trials are expected to start in 2014.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Former AZ oncology head joins Innate Pharma Former AZ oncology head joins Innate Pharma

    Dr Mondher Mahjoubi, formerly AstraZeneca's head of oncology, has moved to lead French biotech Innate Pharma. ... Building on a unique and differentiated expertise in innate immunity, Innate Pharma has been a pioneer in immuno-oncology. “

  • Creabilis names Catherine Moukheibir as chairman of the board Creabilis names Catherine Moukheibir as chairman of the board

    Creabilis names Catherine Moukheibir as chairman of the board. She has previously held roles at Ablynx, Movetis and Innate Pharma. ... Ablynx and member of the management board at Innate Pharma.

  • Novo's Wagtmann joins Innate as chief scientific officer Novo's Wagtmann joins Innate as chief scientific officer

    Innate Pharma has appointed former Novo Nordisk VP Dr Nicolai Wagtmann as chief scientific officer. ... My team at Novo Nordisk has enjoyed very productive interactions with Innate Pharma during a multi-year research collaboration which resulted in three

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics